• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计划再好也会落空?:欧洲抗微生物药物耐药性国家行动计划中的国际治理视角。

The best laid plans?: international governance perspectives in AMR national action plans in Europe.

机构信息

Department of Political Science, University of Gothenburg, Gothenburg, Sweden.

Ministry of Health, Republic of Greece.

出版信息

Eur J Public Health. 2023 Aug 1;33(4):682-686. doi: 10.1093/eurpub/ckad080.

DOI:10.1093/eurpub/ckad080
PMID:37196335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10393504/
Abstract

BACKGROUND

There is a broad consensus in the European public health community that international collaboration and coordination are key in the fight against antimicrobial resistance (AMR). Yet, while experts typically testify the importance of cross-national learning and a coordinated effort to reduce the spread of multi-resistant bacteria, there are mixed views about how that is best realized in practice, particularly on the dichotomy between horizontal and vertical activities.

METHODS

National action plans (NAP) from all EU member states were systematically overviewed by two independent researchers. We followed a fixed procedure for locating a broad and comparable content on the international dimensions, and letting these vary on scales.

RESULTS

We find that countries adhere to four different strategies for international coordination, varying between 'high' and 'low' on values of vertical and horizontal activities. Most countries spend none or very little space to discuss international activities, while some countries use their NAPs to outline their aspiration for taking leading roles in the international struggle. Moreover, in line with previous research, we find that many countries directly mimic the Global Action Plan, but also that a large share of countries describe independent arrangements in their international strategies.

CONCLUSIONS

European countries recognize AMR and its inherent international governance challenge differently in their NAPs, which may have implications for coordinated action to address the issue.

摘要

背景

在欧洲公共卫生界,人们广泛认为国际合作与协调是对抗抗微生物药物耐药性(AMR)的关键。然而,尽管专家通常证明跨国学习和协调努力对于减少多耐药菌传播的重要性,但对于如何在实践中最好地实现这一点,存在着不同的看法,特别是在横向和纵向活动之间的二分法上。

方法

两位独立的研究人员对所有欧盟成员国的国家行动计划进行了系统的综述。我们遵循了一个固定的程序,寻找关于国际层面的广泛而可比的内容,并让这些内容在不同的尺度上有所变化。

结果

我们发现,各国在国际协调方面采取了四种不同的策略,其纵向和横向活动的价值高低不一。大多数国家在讨论国际活动方面没有投入或投入很少,而有些国家则利用国家行动计划来勾勒出他们在国际斗争中发挥主导作用的愿望。此外,与先前的研究一致,我们发现许多国家直接模仿全球行动计划,但也有很大一部分国家在其国际战略中描述了独立的安排。

结论

欧洲各国在其国家行动计划中对 AMR 及其内在的国际治理挑战有不同的认识,这可能对协调行动以解决这一问题产生影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc0/10393504/16cc73488b19/ckad080f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc0/10393504/16cc73488b19/ckad080f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6fc0/10393504/16cc73488b19/ckad080f1.jpg

相似文献

1
The best laid plans?: international governance perspectives in AMR national action plans in Europe.计划再好也会落空?:欧洲抗微生物药物耐药性国家行动计划中的国际治理视角。
Eur J Public Health. 2023 Aug 1;33(4):682-686. doi: 10.1093/eurpub/ckad080.
2
The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.抗微生物药物耐药性的全球治理:全球行动计划与国家行动计划一致性的跨国研究。
Global Health. 2020 Nov 11;16(1):109. doi: 10.1186/s12992-020-00639-3.
3
Coming of age: governance challenges in updated AMR national action plans in the EU.成年:更新的欧盟抗微生物药物耐药性国家行动计划中的治理挑战。
Eur J Public Health. 2024 Oct 1;34(5):885-889. doi: 10.1093/eurpub/ckae067.
4
Fighting Antimicrobial Resistance and Healthcare-Associated Infections in EU-JAMRAI: The One-Health Response from Italy.抗击欧盟抗菌药物耐药性和医疗机构相关感染的联合行动计划:意大利的“同一健康”应对措施。
Chemotherapy. 2024;69(1):56-64. doi: 10.1159/000531684. Epub 2023 Sep 6.
5
Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries.衡量 2020-21 年全球对抗微生物药物耐药性的反应:对 114 个国家的系统治理分析。
Lancet Infect Dis. 2023 Jun;23(6):706-718. doi: 10.1016/S1473-3099(22)00796-4. Epub 2023 Jan 16.
6
Assessment of the inclusion of vaccination as an intervention to reduce antimicrobial resistance in AMR national action plans: a global review.评估将疫苗接种纳入减少抗微生物药物耐药性国家行动计划中的干预措施:全球综述。
Global Health. 2022 Oct 17;18(1):85. doi: 10.1186/s12992-022-00878-6.
7
8
Articulating citizen participation in national anti-microbial resistance plans: a comparison of European countries.阐述公民参与国家抗微生物药物耐药性计划:欧洲国家的比较。
Eur J Public Health. 2018 Oct 1;28(5):928-934. doi: 10.1093/eurpub/cky128.
9
Assessing transparency and accountability of national action plans on antimicrobial resistance in 15 African countries.评估 15 个非洲国家的国家抗微生物药物耐药性行动计划的透明度和问责制。
Antimicrob Resist Infect Control. 2022 Jan 24;11(1):15. doi: 10.1186/s13756-021-01040-4.
10
National action plans on antimicrobial resistance in Latin America: an analysis via a governance framework.拉丁美洲的抗菌药物耐药性国家行动计划:基于治理框架的分析。
Health Policy Plan. 2024 Feb 22;39(2):188-197. doi: 10.1093/heapol/czad118.

引用本文的文献

1
Understanding the veterinary antibiotic flow in Malawi: complexities, gaps and needs.了解马拉维的兽用抗生素流动情况:复杂性、差距与需求。
Front Vet Sci. 2024 Nov 20;11:1474307. doi: 10.3389/fvets.2024.1474307. eCollection 2024.
2
Coming of age: governance challenges in updated AMR national action plans in the EU.成年:更新的欧盟抗微生物药物耐药性国家行动计划中的治理挑战。
Eur J Public Health. 2024 Oct 1;34(5):885-889. doi: 10.1093/eurpub/ckae067.
3
Antimicrobial Resistance and Sports: The Scope of the Problem, Implications for Athletes' Health and Avenues for Collaborative Public Health Action.

本文引用的文献

1
An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations.对现有的国家抗菌素耐药行动计划的分析——在优化人群中抗生素使用的策略方面存在的差距和机遇。
Lancet Glob Health. 2023 Mar;11(3):e466-e474. doi: 10.1016/S2214-109X(23)00019-0. Epub 2023 Feb 2.
2
Measuring the global response to antimicrobial resistance, 2020-21: a systematic governance analysis of 114 countries.衡量 2020-21 年全球对抗微生物药物耐药性的反应:对 114 个国家的系统治理分析。
Lancet Infect Dis. 2023 Jun;23(6):706-718. doi: 10.1016/S1473-3099(22)00796-4. Epub 2023 Jan 16.
3
抗微生物药物耐药性与体育:问题范围、对运动员健康的影响及公共卫生协同行动途径
Antibiotics (Basel). 2024 Feb 29;13(3):232. doi: 10.3390/antibiotics13030232.
Assessment of the inclusion of vaccination as an intervention to reduce antimicrobial resistance in AMR national action plans: a global review.
评估将疫苗接种纳入减少抗微生物药物耐药性国家行动计划中的干预措施:全球综述。
Global Health. 2022 Oct 17;18(1):85. doi: 10.1186/s12992-022-00878-6.
4
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
5
Attention to the Tripartite's one health measures in national action plans on antimicrobial resistance.关注三方的“同一健康”措施在国家抗菌素耐药性行动计划中。
J Public Health Policy. 2021 Jun;42(2):236-248. doi: 10.1057/s41271-021-00277-y. Epub 2021 Feb 17.
6
The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.抗微生物药物耐药性的全球治理:全球行动计划与国家行动计划一致性的跨国研究。
Global Health. 2020 Nov 11;16(1):109. doi: 10.1186/s12992-020-00639-3.
7
National action to combat AMR: a One-Health approach to assess policy priorities in action plans.国家行动打击抗生素耐药性:采用一种“同一健康”方法评估行动计划中的政策重点。
BMJ Glob Health. 2020 Jul;5(7). doi: 10.1136/bmjgh-2020-002427.
8
On the preconditions for large-scale collective action.大规模集体行动的前提条件。
Ambio. 2020 Jul;49(7):1282-1296. doi: 10.1007/s13280-019-01284-w. Epub 2019 Nov 12.
9
A governance framework for development and assessment of national action plans on antimicrobial resistance.国家抗菌素耐药性行动计划制定和评估的治理框架。
Lancet Infect Dis. 2019 Nov;19(11):e371-e384. doi: 10.1016/S1473-3099(19)30415-3. Epub 2019 Oct 3.
10
Articulating citizen participation in national anti-microbial resistance plans: a comparison of European countries.阐述公民参与国家抗微生物药物耐药性计划:欧洲国家的比较。
Eur J Public Health. 2018 Oct 1;28(5):928-934. doi: 10.1093/eurpub/cky128.